Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Galapagos (GLPG)
NASDAQ:GLPG
Holding GLPG?
Track your performance easily
GLPG Stock Chart & Stats
Day’s Range― - ―
52-Week Range$23.45 - $40.34
Previous CloseN/A
Volume251.83K
Average Volume (3M)242.72K
Market Cap
$1.57B
Enterprise Value-$1.86B
Total Cash (Recent Filing)$973.24M
Total Debt (Recent Filing)$9.00K
Price to Earnings (P/E)―
Beta0.75
Next Earnings
Feb 12, 2025EPS Estimate
-0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.32
Shares Outstanding65,897,070
10 Day Avg. Volume322,168
30 Day Avg. Volume242,723
Standard Deviation0.09
R-Squared0.01
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)6.35
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap-1.19
Enterprise Value/Revenue-6.80
Enterprise Value/Gross Profit-7.77
Enterprise Value/Ebitda-38.06
Forecast
1Y Price Target
$29.00Price Target Upside25.16% Upside
Rating ConsensusHold
Number of Analyst Covering5
Galapagos News
PremiumCompany Announcements
Galapagos Reports Promising CAR T-Cell Therapy Results
PremiumCompany Announcements
Galapagos NV Sees Pipeline Growth Amid Financial ChallengesBulls Say, Bears Say
Bulls Say
Clinical AdvancementsGalapagos continues to advance 3 clinical-stage CAR T programs in oncology with promising early efficacy and clean safety data, providing validation for its 7 day vein-to-vein POC CAR T platform.
Restructuring And Business DevelopmentThe restructuring aims to reduce cash burn at legacy GLPG and increase the likelihood of business development by pursuing this within a new entity.
Strategic CollaborationsThe FDA has cleared the IND to expand the ATALANTA trial to the U.S., and Galapagos has entered into a strategic collaboration to further expand its CAR-T production system.
Bears Say
Business StrategyThe challenges of the GILD collaboration structure remain, posing limitations on leveraging GLPG's large cash balance towards value-generating pipeline candidates.
Financial PerformanceGLPG had been trading at a negative enterprise value as lead pipeline assets are still several years from commercialization with unclear differentiation.
Market CompetitionThere is caution on the commercial potential of GLPG's CD19 CAR-Ts, given the company is heading into competitive markets with unclear differentiation.
---
Ownership Overview
―
Insiders
3.08% Mutual Funds
0.06% Other Institutional Investors
96.16% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GLPG FAQ
What was Galapagos’s price range in the past 12 months?
Galapagos lowest stock price was $23.45 and its highest was $40.34 in the past 12 months.
What is Galapagos’s market cap?
Galapagos’s market cap is $1.57B.
When is Galapagos’s upcoming earnings report date?
Galapagos’s upcoming earnings report date is Feb 12, 2025 which is in 12 days.
How were Galapagos’s earnings last quarter?
Galapagos released its earnings results on Oct 30, 2024. The company reported -$0.803 earnings per share for the quarter, missing the consensus estimate of -$0.169 by -$0.634.
Is Galapagos overvalued?
According to Wall Street analysts Galapagos’s price is currently Undervalued.
Does Galapagos pay dividends?
Galapagos does not currently pay dividends.
What is Galapagos’s EPS estimate?
Galapagos’s EPS estimate is -0.55.
How many shares outstanding does Galapagos have?
Galapagos has 65,897,070 shares outstanding.
What happened to Galapagos’s price movement after its last earnings report?
Galapagos reported an EPS of -$0.803 in its last earnings report, missing expectations of -$0.169. Following the earnings report the stock price went down -7.52%.
Which hedge fund is a major shareholder of Galapagos?
Among the largest hedge funds holding Galapagos’s share is Deerfield Management Company, LP. It holds Galapagos’s shares valued at 41M.
---
Galapagos Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$29.00 (25.16% Upside)
$29.00 (25.16% Upside)
Blogger Sentiment
Bullish
GLPG Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 4.7%
Last 30 Days ▲ 4.7%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.08%
12-Months-Change
Fundamentals
Return on Equity
7.21%
Trailing 12-Months
Asset Growth
-1.20%
Trailing 12-Months
Company Description
Galapagos
Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.
---
GLPG Company Deck
---
GLPG Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong strategic and financial position, with significant regulatory achievements and a robust pipeline. However, there were increases in R&D costs and challenges in CAR-T development. The highlights, particularly the strong cash position and regulatory advancements, outweigh the lowlights.Read More>---
GLPG Stock 12 Month Forecast
Average Price Target
$29.00
▲(25.16% Upside)
Technical Analysis
Best Analysts Covering GLPG
1 Year
1 Year Success Rate
5/13 ratings generated profit
1 Year Average Return
+12.25%
reiterated a buy rating 3 months ago
Copying Phil Nadeau's trades and holding each position for 1 Year would result in 38.46% of your transactions generating a profit, with an average return of +12.25% per trade.
---